Romero, Jose Rafael MD
doi : 10.1161/STROKEAHA.123.043310
Volume 54(5) pgs. 1171-1461,e190-e230 May 2023
De Matteis, Eleonora MD; De Santis, Federico MD; Ornello, Raffaele MD, PhD; Censori, Bruno MD; Puglisi, Valentina MD; Vinciguerra, Luisa MD; Giossi, Alessia MD; Di Viesti, Pietro MD; Inchingolo, Vincenzo MD; Fratta, Giovanni Matteo MD; Diomedi, Marina MD; Bagnato, Maria Rosaria MD; Cenciarelli, Silvia MD; Bedetti, Chiara MD;
doi : 10.1161/STROKEAHA.122.041660
Randomized controlled trials (RCTs) proved that short-term (21-90 days) dual antiplatelet therapy (DAPT) reduces the risk of early ischemic recurrences after a noncardioembolic minor stroke or high-risk transient ischemic attack (TIA) without substantially increasing the hemorrhagic risk. We aimed at understanding whether and how real-world use of DAPT differs from RCTs.
Schwarz, Ghil MD; Agostoni, Elio C. MD; Saliou, Guillaume MD, PhD; Hajdu, Steven David MD; Salerno, Alexander MD; Dunet, Vincent MD, PhD; Michel, Patrik MD; Strambo, Davide MD
doi : 10.1161/STROKEAHA.122.041981
Little is known on the role of mismatch profile in patients undergoing early endovascular treatment (EVT). We aimed to describe pretreatment perfusion parameters and mismatch profiles in anterior circulation large vessel occlusion acute ischemic stroke undergoing EVT in the early time window and assess their association with time from stroke onset and outcomes.
Rose, Deborah MD; Cavalier, Annie MD; Kam, Wayneho MD; Cantrell, Sarah MLIS, AHIP; Lusk, Jay BSc; Schrag, Matthew MD, PhD; Yaghi, Shadi MD; Stretz, Christoph MD; de Havenon, Adam MD, MS; Saldanha, Ian J. MBBS, MPH, PhD; Wu, Teddy Y. MBChB, PhD; Ranta, Anna MD, PhD; Barber, P. Alan MBChB, PhD; Marriott, Elizabeth MD; Feng, Wayne MD, MS; Kosinski, Andrzej S. MS, PhD; Laskowitz, Daniel MD; Poli, Sven MD; Mac Grory, Brian MB BCh BAO, MRCP
doi : 10.1161/STROKEAHA.122.042335
Prior systematic reviews have compared the efficacy of intravenous tenecteplase and alteplase in acute ischemic stroke, assigning their relative complications as a secondary objective.
Yan, Chaowu PhD, MD; Li, Hua MD; Wang, Cheng PhD, MD; Yu, Hang MD; Guo, Tingting MD; Wan, Linyuan PhD, MD; Yundan, Pingcuo MD; Wang, Lei PhD, MD; Fang, Wei PhD, MD
doi : 10.1161/STROKEAHA.122.041524
High-resolution optical coherence tomography can detect in situ thrombi within patent foramen ovale (PFO), which can become a dangerous embolic source.
Kaushik, Kanishk MD; van Etten, Ellis S. MD, PhD; Siegerink, Bob PhD; Kappelle, L. Jaap MD, PhD; Lemstra, Afina W. MD, PhD; Schreuder, Floris H.B.M. MD, PhD; Klijn, Catharina J.M. MD, PhD; Peul, Wilco C. MD, PhD; Terwindt, Gisela M. MD, PhD; van Walderveen, Marianne A.A. MD, PhD; Wermer, Marieke J.H. MD, PhD
doi : 10.1161/STROKEAHA.122.041690
Prion-like transmission of amyloid-[latin sharp s] through cadaveric dura, decades after neurosurgical procedures, has been hypothesized as an iatrogenic cause of cerebral amyloid angiopathy (CAA).
Greenberg, Steven M. MD, PhD; Charidimou, Andreas MD, PhD
Sapkota, Shraddha PhD; Erickson, Kelsey BS, BA; Fletcher, Evan PhD; Tomaszewski Farias, Sarah E. PhD; Jin, Lee-Way MD, PhD; DeCarli, Charles MD; for the Alzheimer's Disease Neuroimaging Initiative
doi : 10.1161/STROKEAHA.122.041854
Understanding the neurobiological underpinnings between established multimodal dementia risk factors and noninvasive blood-based biomarkers may lead to greater precision and earlier identification of older adults at risk of accelerated decline and dementia.
Liao, Yi-Chu MD, PhD; Wei, Cheng-Yu MD; Chang, Fu-Pang MD; Chou, Ying-Tsen PhD; Hsu, Shao-Lun MD; Chung, Chih-Ping MD, PhD; Mizuguchi, Takeshi MD, PhD; Matsumoto, Naomichi MD, PhD; Yet, Shaw-Fang PhD; Lee, Yi-Chung MD, PhD
doi : 10.1161/STROKEAHA.122.041848
Neuronal intranuclear inclusion disease (NIID), caused by GGC (guanine-guanine-cytosine) repeat expansion in NOTCH2NLC, has several clinical and radiological features akin to cerebral small vessel disease (cSVD).
Haertl, Johanna MD; Renz, Martin MD; Wunderlich, Silke MD; Hemmer, Bernhard MD; Hofauer, Benedikt MD; Gempt, Jens MD; Kallmayer, Michael MD; Boeckh-Behrens, Tobias MD; Kirschke, Jan S. MD; Ikenberg, Benno David MD
doi : 10.1161/STROKEAHA.122.041946
Bone or cartilage anomalies with affection of brain supplying arteries are a potential structural cause for ischemic stroke. In the following, we termed this entity bony stroke.
Pan, Chensheng MD; Chen, Guohua MD; Jing, Ping MD; Li, Guo PhD; Li, Yuanhao MD; Miao, Jinfeng MD; Sun, Wenzhe MD; Wang, Yanyan MD; Lan, Yan MD; Qiu, Xiuli MD; Zhao, Xin MD; Mei, Junhua MD; Huang, Shanshan MD, PhD; Lian, Lifei MD; Zhu, Zhou MD, PhD; Zhu, Suiqiang MD
doi : 10.1161/STROKEAHA.122.042127
Poststroke cognitive impairment (PSCI) is highly prevalent in stroke survivors and correlated with unfavorable clinical outcomes. This study aimed to identify the neural substrate of PSCI using atlas-based disconnectome analysis and assess the value of disconnection score, a baseline measure for stroke-induced structural disconnection, in PSCI prediction.
Ueki, Kana MD; Matsuo, Ryu MD, PhD; Kuwashiro, Takahiro MD, PhD; Irie, Fumi MD, PhD; Wakisaka, Yoshinobu MD, PhD; Ago, Tetsuro MD, PhD; Kamouchi, Masahiro MD, PhD; Kitazono, Takanari MD, PhD; on behalf of the Fukuoka Stroke Registry Investigators; Ishitsuka, Takao MD, PhD; Ibayashi, Setsuro MD, PhD; Chair; Kusuda, Kenji MD, PhD; Fujii, Kenichiro MD, PhD; Nagao, Tetsuhiko MD, PhD; Okada, Yasushi MD, PhD; Vice-Chair; Yasaka, Masahiro MD, PhD; Ooboshi, Hiroaki MD, PhD; Irie, Katsumi MD, PhD; Omae, Tsuyoshi MD, PhD; Toyoda, Kazunori MD, PhD; Nakane, Hiroshi MD, PhD; Sugimori, Hiroshi MD, PhD; Arakawa, Shuji MD, PhD; Fukuda, Kenji MD, PhD; Kitayama, Jiro MD, PhD; Fujimoto, Shigeru MD, PhD; Arihiro, Shoji MD; Kuroda, Junya MD, PhD; Fukushima, Yoshihisa MD; Nakamura, Kuniyuki MD, PhD; Kiyohara, Takuya MD, PhD; Hata, Jun MD, PhD; Kumai, Yasuhiro MD, PhD
doi : 10.1161/STROKEAHA.122.040958
It remains unclear how chronic kidney disease and its underlying pathological conditions, kidney dysfunction, and kidney damage, are associated with cardiovascular outcomes.
Bruce, Samuel S. MD, MA; Parikh, Neal S. MD, MS
Sedaghat, Sanaz PhD; Ji, Yuekai MSc; Empana, Jean-Philippe PhD; Hughes, Timothy M. PhD; Mosley, Thomas H. PhD; Gottesman, Rebecca F. MD; Griswold, Michael PhD; Jack, Clifford R. Jr MD; Lutsey, Pamela L. PhD; van Sloten, Thomas T. MD
doi : 10.1161/STROKEAHA.122.041374
Cardiovascular health may be used for prevention of cerebral vascular disease; however, data on the association of cardiovascular health across midlife and late-life with late-life cerebral vascular disease are lacking.
McCabe, John J. PhD ,,,*; Walsh, Cathal PhD ,,*; Gorey, Sarah MB; Harris, Katie PhD; Hervella, Pablo PhD; Iglesias-Rey, Ramon PhD; Jern, Christina PhD; Li, Linxin DPhil; Miyamoto, Nobukazu MD; Montaner, Joan PhD; Pedersen, Annie PhD; Purroy, Francisco PhD; Rothwell, Peter M. FMedSci; Sudlow, Catherine PhD; Ueno, Yuji MD; Vicente-Pascual, Mikel MD; Whiteley, William PhD; Woodward, Mark PhD; Kelly, Peter J. MD
doi : 10.1161/STROKEAHA.122.040529
Anti-inflammatory therapies reduce recurrent vascular events in coronary disease. Existing studies have reported highly conflicting findings for the association of blood inflammatory markers with vascular recurrence after stroke leading to uncertainty about the potential of anti-inflammatory therapies after stroke and no consensus about the utility of measurement of inflammatory markers in current guidelines.
Boghozian, Roobina PhD; Falcione, Sarina BSc; Jickling, Glen C. MD
Sandvig, Heidi Vihovde MD; Aam, Stina MD, PhD; Alme, Katinka Nordheim MD, PhD; Askim, Torunn PhD; Beyer, Mona K. MD, PhD; Ellekjaer, Hanne MD, PhD; Ihle-Hansen, Hege MD, PhD; Lydersen, Stian PhD; Mollnes, Tom Eirik MD, PhD; Munthe-Kaas, Ragnhild MD, PhD; Naess, Halvor MD, PhD; Saltvedt, Ingvild MD, PhD; Seljeseth, Yngve Muller MD; Thingstad, Pernille PhD; Wethal, Torgeir MD, PhD; Knapskog, Anne-Brita MD, PhD
doi : 10.1161/STROKEAHA.122.041965
Inflammation is proposed to be involved in the pathogenesis of poststroke cognitive impairment. The aim of this study was to investigate associations between concentrations of systemic inflammatory biomarkers after ischemic stroke and poststroke cognitive impairment.
Duan, Youling MD; Zhao, Dong MD, PhD; Sun, Jiayi MD; Liu, Jun MD; Wang, Miao MD, PhD; Hao, Yongchen MD, PhD; Li, Jiangtao MD; Liu, Tianxiao MD; Xiao, Luoxi MD; Hao, Yiming MD; Wang, Haimei MD; Qi, Yue MD, PhD; Liu, Jing MD, PhD
doi : 10.1161/STROKEAHA.122.042323
Although important progress has been made in understanding Lp(a) (lipoprotein[a])-mediated stroke risk, the contribution of Lp(a) to the progression of vulnerable plaque features associated with stroke risk remains unclear.
Oh, Daniel M. MD; Markovic, Daniela MS; Towfighi, Amytis MD
doi : 10.1161/STROKEAHA.122.038133
Patients with stroke in the United States can be transferred for higher level of care. Little is known about possible inequities in interhospital transfers (IHTs) for acute ischemic stroke.
Pu, Liyuan MPH ,,*; Wang, Li MM ,*; Zhang, Ruijie MM; Zhao, Tian MM; Jiang, Yannan BS; Han, Liyuan MD
doi : 10.1161/STROKEAHA.122.040073
We projected global trends in ischemic stroke from 2020 to 2030 according to age, sex, and socio-demographic index (SDI) quintile.
Sun, Jiangming PhD; Borne, Yan PhD; Edsfeldt, Andreas MD, PhD; Wang, Yunpeng PhD; Pan, Mengyu MS; Regeneron Genetics Center; Melander, Olle MD, PhD; Engstrom, Gunnar MD, PhD; Goncalves, Isabel MD, PhD; Abecasis, Goncalo Ph.D.; Baras, Aris M.D.; Cantor, Michael M.D.; Coppola, Giovanni M.D.; Economides, Aris Ph.D.; Lotta, Luca A. M.D., Ph.D.; Overton, John D. Ph.D.; Reid, Jeffrey G. Ph.D.; Shuldiner, Alan M.D.; Beechert, Christina; Forsythe, Caitlin M.S.; Fuller, Erin D.; Gu, Zhenhua M.S.; Lattari, Michael; Lopez, Alexander M.S.; Overton, John D. Ph.D.; Schleicher, Thomas D. M.S.; Padilla, Maria Sotiropoulos M.S.; Toledo, Karina; Widom, Louis; Wolf, Sarah E. M.S.; Pradhan, Manasi M.S.; Manoochehri, Kia; Ulloa, Ricardo H.; Bai, Xiaodong Ph.D.; Balasubramanian, Suganthi Ph.D.; Barnard, Leland Ph.D.; Blumenfeld, Andrew; Eom, Gisu; Habegger, Lukas Ph.D.; Hahn, Young; Hawes, Alicia B.S.; Khalid, Shareef; Reid, Jeffrey G. Ph.D.; Maxwell, Evan K. Ph.D.; Salerno, William Ph.D.; Staples, Jeffrey C. Ph.D.; Yadav, Ashish M.S.; Jones, Marcus B. Ph.D.; Mitnaul, Lyndon J. Ph.D.
doi : 10.1161/STROKEAHA.122.041026
Mood disorders and strokes are often comorbid, and their health toll worldwide is huge. This study characterizes prognostic and causal roles of mood disorders in stroke.
Schupper, Alexander J. MD; Hardigan, Trevor A. MD, PhD; Mehta, Amol MD; Yim, Benjamin MD; Yaeger, Kurt A. MD; De Leacy, Reade MD; Fifi, Johanna T. MD; Mocco, J MD; Majidi, Shahram MD
doi : 10.1161/STROKEAHA.122.041488
Aneurysmal subarachnoid hemorrhage is associated with high rate of morbidity and mortality. We aimed to assess prognostic impact of sex, race, and ethnicity in these patients.
Yang, Xiaoxu MD ,*; Yu, Pengxin MSc ,*; Zhang, Haoyue MSc; Zhang, Rongguo PhD; Liu, Yuehong MD; Li, Haoyuan MD; Sun, Penghui MSc; Liu, Xin MD; Wu, Yu MSc; Jia, Xiuqin PhD; Duan, Jiangang MD, PhD; Ji, Xunming MD, PhD; Yang, Qi MD, PhD
doi : 10.1161/STROKEAHA.122.041520
Cerebral venous thrombosis (CVT) is a rare cerebrovascular disease. Routine brain magnetic resonance imaging is commonly used to diagnose CVT.
Li, Hao MD; Cai, Mengfei MD, PhD; Jacob, Mina A. MD; Norris, David G. PhD; Marques, Jose P. PhD; Chamberland, Maxime PhD; Duering, Marco MD; Kessels, Roy P.C. MD, PhD; de Leeuw, Frank-Erik MD, PhD; Tuladhar, Anil M. MD, PhD
doi : 10.1161/STROKEAHA.122.041687
Structural network damage is a potentially important mechanism by which cerebral small vessel disease (SVD) can cause cognitive impairment. As a central hub of the structural network, the role of thalamus in SVD-related cognitive impairments remains unclear.
Deng, Yiming MD, PhD; Li, Zeyan MSc; Sun, Xuan MD, PhD; Ma, Ning MD, PhD; Song, Ligang MD, PhD; Chen, Duanduan PhD; Gao, Feng MD, PhD
doi : 10.1161/STROKEAHA.122.038757
Neuroinflammation plays extremely crucial roles in the neurological damage mediated by ischemic stroke. TRIM29 (tripartite motif containing 29) has previously been proposed to contribute to the regulation of innate immunity, however, the effect of TRIM29 on ischemic stroke induced neurodegenerative processes and neuroinflammation still largely unexplored.
Ihle-Hansen, Hakon MD, PhD; Boas, Hakon PhD; Tapia, German PhD; Hagberg, Guri MD, PhD; Ihle-Hansen, Hege MD, PhD; Berild, Jacob Dag MD; Selmer, Randi MD, PhD; Karlstad, Oystein PhD; Gulseth, Hanne Lovdal MD, PhD; Ariansen, Inger MD, PhD
doi : 10.1161/STROKEAHA.122.040430
Whether the SARS-CoV-2 mRNA vaccines may cause a transient increased stroke risk is uncertain.
de Havenon, Adam MD, MS; Zhou, Lily W. MD, MS; Yaghi, Shadi MD; Frontera, Jennifer A. MD; Sheth, Kevin N. MD
doi : 10.1161/STROKEAHA.122.041929
There is a paucity of nationally representative data regarding the impact of COVID-19 on acute ischemic stroke (AIS) outcome.
Zhang, Haiqing PhD ,*; Lai, Xuefeng; Fang, Qin PhD; Ma, Lin MM; Liu, Miao PhD; Yang, Huihua PhD; Guo, Wenting PhD; He, Meian PhD; Yang, Liangle PhD; Zhang, Xiaomin PhD
de Havenon, Adam MD; Bangad, Aaron BA; Skolarus, Lesli E. MD, MS; Aldridge, Chad M. DPT; Braun, Robynne G. MD, PhD; Cole, John W. MD; Cramer, Steven C. MD; Lindgren, Arne G. MD, PhD; Sunmonu, N. Abimbola MD, PhD; Worrall, Bradford B. MD, MSc; Lohse, Keith R. PhD
Bahr-Hosseini, Mersedeh MD ,,*; Mei[latin sharp s]ner, Nina ,*; Reidler, Paul MD; Saver, Jeffrey L. MD; Tiedt, Steffen MD, PhD
Abdalkader, Mohamad MD; Shulman, Julie G. MD; Sahoo, Anurag MD; Ford, Thomas MD; Nguyen, Thanh N. MD
Psychogios, Klearchos MD; Kargiotis, Odysseas MD; Safouris, Apostolos MD; Repousis, Panagiotis MD; Tsivgoulis, Georgios MD
Kaiser, Daniel P.O. MD; Gawlitza, Matthias MD; Linn, Jennifer MD; Engellandt, Kay MD
Hiraga, Akiyuki MD; Kurumada, Kentaro MD; Kojima, Kazuho MD; Kuwabara, Satoshi MD
Adelman, Eric E. MD; Leppert, Michelle H. MD, MBA
Petersen, Nils H. MD; Sheth, Kevin N. MD; Jha, Ruchira M. MD
doi : 10.1161/STROKEAHA.122.036402
AB Scientific advances have informed many aspects of acute stroke care but have also highlighted the complexity and heterogeneity of cerebrovascular diseases.
Stamenkovic, Stefan PhD ,*; Li, Yuandong PhD ,*; Waters, Jack PhD; Shih, Andy PhD
doi : 10.1161/STROKEAHA.122.037156
AB The increasing socio-economic burden of Alzheimer disease (AD) and AD-related dementias has created a pressing need to define targets for therapeutic intervention.
Richards, Christopher T. MD, MS; Oostema, J. Adam MD, MS; Chapman, Sherita N. MD; Mamer, Lauren E. MD, PhD; Brandler, Ethan S. MD, MPH; Alexandrov, Anne W. PhD, AGACNP-BC, ANVP-BC; Czap, Alexandra L. MD; Martinez-Gutierrez, Juan Carlos MD; Martin-Gill, Christian MD, MPH; Panchal, Ashish R. MD, PhD; McMullan, Jason T. MD, MS; Zachrison, Kori S. MD, MSc
doi : 10.1161/STROKEAHA.123.039792
AB The prehospital phase is a critical component of delivering high-quality acute stroke care. This topical review discusses the current state of prehospital acute stroke screening and transport, as well as new and emerging advances in prehospital diagnosis and treatment of acute stroke.
Lauzier, David C. BS; Jayaraman, Keshav BA; Yuan, Jane Y. BS; Diwan, Deepti PhD; Vellimana, Ananth K. MD; Osbun, Joshua W. MD, MSCI; Chatterjee, Arindam R. MD; Athiraman, Umeshkumar MD; Dhar, Rajat MD; Zipfel, Gregory J. MD
doi : 10.1161/STROKEAHA.122.040072
AB Aneurysmal subarachnoid hemorrhage is a devastating condition causing significant morbidity and mortality. While outcomes from subarachnoid hemorrhage have improved in recent years, there continues to be significant interest in identifying therapeutic targets for this disease.
Williams, David M. MBBS, MSc; Atkinson, Michael BMus, MBBCh; Evans, Marc MD
doi : 10.1161/STROKEAHA.122.042109
AB Stroke is a leading cause of disability and death, and people with type 2 diabetes (T2D) have a greater risk of stroke and death or disability from stroke.
Brott, Thomas G. MD; Meschia, James F. MD; Lal, Brajesh K. MD; Chamorro, Angel MD; Howard, Virginia J. PhD; Howard, George DrPH
doi : 10.1161/STROKEAHA.122.042172
AB The recently published SPACE-2 trial (Stent-Supported Percutaneous Angioplasty of the Carotid Artery Versus Endarterectomy-2) compared 3 treatments to prevent stroke in patients with asymptomatic carotid stenosis >=70%: (1) carotid endarterectomy plus best medical treatment (BMT), (2) transfemoral carotid artery stenting plus BMT, or (3) BMT alone.
Morris, Nicholas A. MD; Jindal, Gaurav MD; Chaturvedi, Seemant MD
doi : 10.1161/STROKEAHA.122.041949
AB Optimal blood pressure targets following successful mechanical thrombectomy remain uncertain. While some observational studies suggest that the relationship between blood pressure and outcomes follows a U-shaped curve, others suggest a linear relationship where lower is better.
Hackett, Maree L. PhD; Allida, Sabine PhD; House, Allan O. DM
Lendaris, Andrea MD, MS; Esenwa, Charles MD, MS
Jagolino-Cole, Amanda L. MD ,*; Zha, Alicia M. MD ,*; Sangha, Navdeep MD; Song, Shlee S. MD; Majersik, Jennifer J. MD, MS
Slawski, Diana MD; Lyman, Kyle A. MD, PhD; Thatikunta, Prateek MD; Gold, Carl A. MD, MS; Albers, Gregory W. MD
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟